Cytosorbents - נכסים נקיים למניה בודדת CTSO

Cytosorbents is scaling sales of blood purification systems within the hospital segment. The book value per share trend visualizes this growth, where -0.24 represents the current level of the metric. Patent protection and complex certifications in the EU and US block competitors from entering the market. Simultaneously, management is expanding the list of medical indications and implementing filters for critical care therapy.

Book value per share represents the difference between all company assets and liabilities divided by the number of outstanding shares, which determines the actual value of an investor's stake upon business liquidation. By analyzing the book value per share indicator, one can assess the capital stability of Cytosorbents (CTSO), which is supported by high-margin revenues from regular sales of disposable cartridges for blood purification systems.